Depot Neuroleptic Therapy: Clinical Considerations
Authors:
- 1 April 1995
- journal article
- research article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 40 (3_suppl) , 5-11
Abstract
The management of schizophrenia is generally a long-term process with neuroleptics representing the cornerstone of treatment. Although not without their own limitations, depot neuroleptics offer an important alternative to oral agents, and they should be routinely considered as an option in any long-term treatment planning. The present article reviews depot neuroleptics, and focuses particularly on clinical considerations pertaining to their use.Keywords
This publication has 49 references indexed in Scilit:
- The neuroleptics: a historical surveyActa Psychiatrica Scandinavica, 1990
- The prevalence of depot neuroleptic treatment among West Indians and Asians in the London borough of NewhamSocial Psychiatry and Psychiatric Epidemiology, 1988
- Double-Blind Comparison of Half-Dose and Standard-Dose Flupenthixol Decanoate in the Maintenance Treatment of Stabilised Out-Patients with SchizophreniaThe British Journal of Psychiatry, 1987
- Haloperidol DecanoateDrugs, 1987
- Depot NeurolepticsJournal of Clinical Psychopharmacology, 1986
- Commentary: The Strategy and Value of Neuroleptic Drug MonitoringJournal of Clinical Psychopharmacology, 1985
- Clinical Pharmacokinetics of the Depot AntipsychoticsClinical Pharmacokinetics, 1985
- Technique for Injecting Long-Acting NeurolepticsThe British Journal of Psychiatry, 1982
- Theoretical and practical importance of plasma levels of haloperidol. correlations with clinical and computerized EEG dataProgress in Neuro-Psychopharmacology, 1981
- Drug defaulting by patients on long-acting phenothiazinesPsychological Medicine, 1973